胸外科术后感染中应用头孢呋辛、头孢美唑与拉氧头孢的成本-效果分析

目的：对头孢呋辛、头抱美唑与拉氧头孢应用于胸外科术后感染中成本一效果进行分析和探讨。方法：选择从2012年12月至2014年12月在本院接受肺部切除手术的肺癌患者150例，以50例为l组，随机分为甲、乙、丙三组，甲组行头孢呋辛抗菌治疗，乙组行头孢美唑抗菌治疗，丙组行拉氧头孢抗菌治疗，对三组治疗效果的进行最小成本分析。结果：三组治疗有效率分别是880％、80．0％、88．0％，比较差异不具有统计学意义（P〉0．05）；三纽的成本分别是（10235±2945）元、（1585．3±626．4）元、（4781．4±1505．98），比较差异具有统计学意义（P〈0．05）。结论：在同等的治疗效果和安全性下，头孢呋辛抗菌治疗胸外科术患者最为经济，能有效降低患者的经济负担，值得推广。

Objective： to cefuroxime, used in thoracic surgery postoperative infection of cost - effectiveness analysis and discussion. Methods： from December 2012 to December 2014 in our hospital for lung resection surgery of 150 eases of patients with lung cancer, is 1 group with 50 cases, were randomly divided into three groups a, b, c, students＇ line of ce- furoxime antibacterial treatment, in line of, c group of line drawing oxygen eephalosporin antibiotic treatment, the treatment effects of three groups of minimum cost analysis. Results： three groups of treatment effectiveness respectively is 88.0%, 80. 0%, 88.0%, and is no statistically significant difference （ P 〉 0. 05 ） ; Cost are the three groups （ 1023.5 ＋ 294. 5 ） yuan, （ 1585.3 -626. 4）, （4781.4 - 1505.98）, compare the differences statistically significant （P〈 0. 05 ）. Conclusion： under the same therapeutic effect and safety of cefuroxime antimicrobial treatment for thoracic surgery patients the most economical, can effectively reduce the economic burden of patients, is worth promoting.